Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. William Aird

Classical Hematology · BIDMC

View

Dr. Cynthia Dunbar

Classical Hematology · NIH

View

Dr. Ariela Marshall

Hemostasis & Thrombosis · University of Minnesota

View

Dr. Philip Schauer

Bariatric Surgery · PBRC

View

Dr. Justin Hovey, FAAP, FACP, DABOM

Obesity Medicine · Noland Hospital Dothan II

View

Dr. Kimberly Gudzune

Obesity Medicine · JHU

View

Dr. Richard Dutton

General Anesthesiology · UMSOM

View

Dr. Sarah Ro

Obesity Medicine · UNC Health Care

View

Dr. Rebecca Andrews

Primary Care · UCHC

View

Dr. Jed Wolpaw

General Anesthesiology · Johns Hopkins

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    RT

    Dr. Richard Travers

    Classical Hematology
    Tufts Medical Center
    richardtravers

    Research

    Permissive Cardiotoxicity and Determination of Anthracycline Risk With Previous Anthracycline Exposure.

    2025

    Via JACC: Case Reports

    Aug 5, 2025Journal Article

    Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke.

    ​

    Written by 1 Roon author & 10 others

    Via The American Heart Association Journals

    Research

    Distinct endothelial cell toxicities of Abl tyrosine kinase inhibitors lead to arterial thrombosis.

    2025

    Via Blood Vessels, Thrombosis & Hemostasis

    Research

    Antipolyphosphate monoclonal antibodies derived from autoimmune mice.

    2024

    Via Research and Practice in Thrombosis and Haemostasis

    Research

    Identifying mitigating strategies for endothelial cell dysfunction and hypertension in response to VEGF receptor inhibitors.

    2024

    Via Clinical Science (London)

    Aug 15, 2024Journal Article

    Endothelium as a Source of Cardiovascular Toxicity From Antitumor Kinase Inhibitors.

    ​

    Written by 1 Roon author & 2 others

    Via The American Heart Association Journals

    Research

    Differential vascular endothelial cell toxicity of established and novel BCR-ABL tyrosine kinase inhibitors.

    2023

    Via PLOS ONE

    Research

    VEGF Receptor Inhibitor-Induced Hypertension: Emerging Mechanisms and Clinical Implications.

    2022

    Via Current Oncology Reports

    Research

    ROCK and Rolling Towards Predicting BCR-ABL Kinase Inhibitor-Induced Vascular Toxicity.

    2022

    Via JACC: CardioOncology

    Research

    Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor.

    2016

    Via Blood

    Research

    Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia.

    2016

    Via Blood Advances

    Research

    How it all starts: Initiation of the clotting cascade.

    2015

    Via Critical Reviews in Biochemistry and Molecular Biology

    Research

    Polyphosphate, platelets, and coagulation.

    2015

    Via International Journal of Laboratory Hematology

    Research

    FXIa and platelet polyphosphate as therapeutic targets during human blood clotting on collagen/tissue factor surfaces under flow.

    2015

    Via Blood

    Research

    Affinity-based design of a synthetic universal reversal agent for heparin anticoagulants.

    2014

    Via Science Translational Medicine